Table 2. Comparison of Alternative Potential Stock Epinephrine Strategies.
| Strategy | Cost (95% CI), $ | Effectiveness (95% CI), QALYs | ICER, $ |
|---|---|---|---|
| No school undesignated epinephrine supply | 107 816 (107 382-108 250) | 26.867 (26.839-26.896) | NA |
| School undesignated supplemental epinephrine supply (supplemental model) | 108 160 (107 725-108 595) | 26.869 (26.841-26.897) | 268 811 per QALYa |
| School undesignated universal epinephrine supply (universal model) | 100 397 (99 979-100 815) | Dominated |
Abbreviations: ICER, incremental cost-effectiveness ratio; NA, not applicable; QALY, quality-adjusted life-year.
a
Supplemental model vs no school undesignated epinephrine supply.